Literature DB >> 12738392

Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.

Jacqueline I Keenan1, Sjoerd G Rijpkema, Zarmina Durrani, Justin A Roake.   

Abstract

Mice and guinea pigs were intranasally immunized with either recombinant lipoprotein 20 or Helicobacter pylori outer membrane vesicles (OMV). Cholera toxin was used as mucosal adjuvant. In mice, both vaccines elicited systemic and local IgG responses, which correlated with significantly lower levels of H. pylori colonization. In contrast, only OMV proved immunogenic in guinea pigs, with the development of both systemic and local immune responses. These antibodies did not, however, correlate with protection in these animals, which suggests that vaccine formulation is as important as choice of antigen in the development of an H. pylori vaccine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738392     DOI: 10.1016/S0928-8244(03)00091-9

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  13 in total

Review 1.  Tiny RNAs and their voyage via extracellular vesicles: Secretion of bacterial small RNA and eukaryotic microRNA.

Authors:  Ji-Woong Choi; Jee-Hyun Um; Jin-Hyun Cho; Heon-Jin Lee
Journal:  Exp Biol Med (Maywood)       Date:  2017-07-25

2.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

3.  Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Zhen-Xing Tu; Yan-Fang Gong; Jing Jin; Hong-Yu Wu; Guo-Ming Xu
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Yan-Fang Gong; Hua Yang; Bo Sun; Jing Jin
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

Review 5.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

6.  Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice.

Authors:  Jennifer M Taylor; Melanie E Ziman; Don R Canfield; Michael Vajdy; Jay V Solnick
Journal:  Microb Pathog       Date:  2007-07-05       Impact factor: 3.738

7.  Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.

Authors:  Anke Ziegenbalg; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Ryung S Kim; Arturo Casadevall; Jacqueline M Achkar
Journal:  Tuberculosis (Edinb)       Date:  2013-04-02       Impact factor: 3.131

8.  Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.

Authors:  Jennifer M Taylor; Melanie E Ziman; Julie Fong; Jay V Solnick; Michael Vajdy
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

9.  Establishment of Helicobacter pylori infection model in Mongolian gerbils.

Authors:  Jie Yan; Yi-Hui Luo; Ya-Fei Mao
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

10.  High yield production process for Shigella outer membrane particles.

Authors:  Francesco Berlanda Scorza; Anna Maria Colucci; Luana Maggiore; Silvia Sanzone; Omar Rossi; Ilaria Ferlenghi; Isabella Pesce; Mariaelena Caboni; Nathalie Norais; Vito Di Cioccio; Allan Saul; Christiane Gerke
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.